Morgan Stanley’s CRH Medical Corporation CRHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,894,545
| Closed | -$11.4M | – | 7976 |
|
|
2021
Q1 | $11.4M | Buy |
2,894,545
+1,580,845
| +120% | +$5.11M | ﹤0.01% | 2509 |
|
|
2020
Q4 | $3.06M | Sell |
1,313,700
-24,345
| -2% | -$59.7K | ﹤0.01% | 3782 |
|
|
2020
Q3 | $2.9M | Sell |
1,338,045
-64,300
| -5% | -$150K | ﹤0.01% | 3289 |
|
|
2020
Q2 | $2.9M | Sell |
1,402,345
-1,518,000
| -52% | -$3.07M | ﹤0.01% | 3226 |
|
|
2020
Q1 | $3.91M | Sell |
2,920,345
-781,662
| -21% | -$2.55M | ﹤0.01% | 2688 |
|
|
2019
Q4 | $12.8M | Sell |
3,702,007
-242,845
| -6% | -$767K | ﹤0.01% | 2121 |
|
|
2019
Q3 | $12.2M | Buy |
3,944,852
+1,568,287
| +66% | +$4.65M | ﹤0.01% | 1925 |
|
|
2019
Q2 | $7.2M | Sell |
2,376,565
-401,053
| -14% | -$1.15M | ﹤0.01% | 2520 |
|
|
2019
Q1 | $7.39M | Sell |
2,777,618
-619,186
| -18% | -$1.91M | ﹤0.01% | 2339 |
|
|
2018
Q4 | $10.4M | Sell |
3,396,804
-256,656
| -7% | -$846K | ﹤0.01% | 2089 |
|
|
2018
Q3 | $14.4M | Buy |
3,653,460
+1,967,537
| +117% | +$7.25M | ﹤0.01% | 2015 |
|
|
2018
Q2 | $5.23M | Buy |
1,685,923
+491,482
| +41% | +$1.57M | ﹤0.01% | 3090 |
|
|
2018
Q1 | $3.05M | Sell |
1,194,441
-86,949
| -7% | -$244K | ﹤0.01% | 3587 |
|
|
2017
Q4 | $3.4M | Sell |
1,281,390
-7,211
| -0.6% | -$16.1K | ﹤0.01% | 3512 |
|
|
2017
Q3 | $3.35M | Buy |
1,288,601
+53,880
| +4% | +$166K | ﹤0.01% | 3380 |
|
|
2017
Q2 | $7.04M | Sell |
1,234,721
-53,564
| -4% | -$348K | ﹤0.01% | 2503 |
|
|
2017
Q1 | $10.6M | Buy |
1,288,285
+652,737
| +103% | +$4.51M | ﹤0.01% | 2141 |
|
|
2016
Q4 | $3.34M | Buy |
635,548
+477,748
| +303% | +$2.42M | ﹤0.01% | 3413 |
|
|
2016
Q3 | $601K | Buy |
157,800
+121,600
| +336% | +$465K | ﹤0.01% | 4411 |
|
|
2016
Q2 | $142K | Sell |
36,200
-24,000
| -40% | -$78.5K | ﹤0.01% | 5089 |
|
|
2016
Q1 | $198K | Buy |
60,200
+31,700
| +111% | +$90.8K | ﹤0.01% | 4981 |
|
|
2015
Q4 | $84K | Buy |
28,500
+18,300
| +179% | +$50.7K | ﹤0.01% | 5498 |
|
|
2015
Q3 | $33K | Buy |
+10,200
| New | +$36.9K | ﹤0.01% | 5880 |
|
Morgan Stanley's CRHM Position: Q2 2021 in Review
Morgan Stanley sold out of CRH Medical Corporation (CRHM) in Q2 2021, closing a stake of 2,894,545 shares — an estimated $11.4M sold.
Morgan Stanley first reported a position in CRHM in Q3 2015 and held it in 23 quarters. The position peaked at $14.4M in Q3 2018. 1 fund tracked by Wall St. Rank holds CRHM as of Q2 2021.
- Morgan Stanley reported no remaining CRH Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Morgan Stanley sold 2,894,545 CRH Medical Corporation shares in Q2 2021, an estimated $11.4M.
- Morgan Stanley first reported a position in CRH Medical Corporation in Q3 2015 and held it in 23 quarters.
- Morgan Stanley's CRH Medical Corporation position peaked at $14.4M in Q3 2018.
- 1 fund tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2021.
Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.